Mindray North America Introduces the A-Series Advantage Platform and TE7 Crystal Series Ultrasound Upgrade at the Anesthesiology 2018 Annual Conference
MAHWAH, N.J., Oct. 17, 2018
MAHWAH, N.J., Oct. 17, 2018 /PRNewswire-PRWeb/ -- Mindray, a leading developer of next generation medical technology, introduced a new anesthesia platform and ultrasound upgrade at the annual Anesthesiology 2018 conference held October 13 – 15, 2018 in San Francisco. With an unwavering commitment to perioperative care, Mindray offers anesthesiologists enhanced functionality in anesthesia delivery and ultrasound needle guidance.
"Central to Mindray's vision of 'better healthcare for all' is a dedication to developing innovative, best in class solutions that enhance clinical workflow, accurately monitor patient status and are easy to implement and maintain," said Mindray North America President Wayne Quinn. "Mindray's comprehensive perioperative solutions offer compelling benefits that enhance patient care and improve user satisfaction."
The new A-Series Advantage anesthesia delivery platform offers customer-focused scalability to meet clinical and budgetary needs, which may change over time. Advanced ventilation modes and functionality for the most challenging patients, from neonatal to bariatrics, include airway pressure release ventilation (APRV) mode and lung recruitment support, as well as the OptimizerTM low flow decision support tool and enhanced data integration and connectivity.
The modular flexibility of A-Series Advantage allows healthcare facilities to build an ideal system configuration, from ambulatory surgery to the advanced surgical suite. The A-Series Advantage platform takes Mindray's already popular A-Series anesthesia delivery systems to a new level; with three basic models to choose from, the A-Series Advantage delivers advanced features and functionality that can be customized making it ideal for standardization throughout a hospital network.
Mindray also showcased a significant new upgrade for its TE7 ultrasound system at the conference. As part of Mindray's recently introduced Gem upgrades, the TE7 Crystal Series features new transducers, voice recognition technology and an industry first transducer tracking technology for reducing health care-associated infections and the spread of infectious disease.
The Crystal Upgrade also features numerous needle visualization advancements including eSpacial Navi™, a 4D magnetic needle navigation technology that delivers enhanced needle visualization and location during interventional procedures. Additionally, precise cardiac imaging with single crystal transducer technology and transesophageal (TEE) capabilities are available. All of Mindray's Point-of-Care ultrasound systems provide a 5-year, state-of-the-art guarantee and include a robust set of Cybersecurity features with M-Secure.
Mindray is a leading developer, manufacturer and marketer of medical devices worldwide. Mindray maintains its global headquarters in Shenzhen, China; North American headquarters in Mahwah, New Jersey; and multiple development facilities and offices in major international markets including an Ultrasound Innovation Center in Silicon Valley. Mindray supplies a broad range of products across three primary business segments, patient monitoring and life support, in-vitro diagnostics, and medical imaging systems. For more information, please visit http://www.mindray.com.
# # #